Monday, November 9, 2026

Health Care,

Egypt Turns 25 Years of Gaucher Care Into a Global Rare-Disease Asset

Egypt has built one of the world’s most significant long-term clinical records on type 3 Gaucher disease while sustaining...

Kahira Pharmaceuticals Profit Climbs 24.5% as Margins Improve

CAIRO — Kahira Pharmaceuticals and Chemical Industries reported a 24.5% rise in FY 2025/26 net profit to EGP552.5mn, with...

The Middle East Observer

Each story in our ever growing library can be accessed through our membership program. Subscribe and receive instantaneous and unlimited access!

spot_img

Don't Miss